ATX-MS-1467, An Immunotolerizing Agent, Halts Disease Progression and Reduces CNS Inflammation in Rodent Models of Multiple Sclerosis (P1.216) Dellovade T, Rudin S, Zozulya A, Tomkinson B Accessed on 6 Oct 2014 from http://www.neurology.org/content/82/10_Supplement/P1.216. Neurology, April 8, 2014, vol. 82 no. 10, Supplement P1.216 CommentRecommendBookmarkWatch
Neurology, April 8, 2014, vol. 82 no. 10, Supplement P1.216